Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke - Wikidata - wikimedia - TriplyDB

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

http://www.wikidata.org/entity/Q34095488

about

Correlating interleukin-10 promoter gene polymorphisms with human cerebral infarction onset.Improved plaque neovascularization following 2-year atorvastatin therapy based on contrast-enhanced ultrasonography: A pilot study.

P2860

Q36443630-7A0784A3-CD7D-4DCE-A892-E4B434D239D5 Q54960992-4602C44D-FFEF-4D39-A4C4-66595EDCA5A8

P2860

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

http://www.wikidata.org/entity/Q34095488

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@ast

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@en

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@nl

type

label

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@ast

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@en

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@nl

prefLabel

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@ast

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@en

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@nl

P1433

Q34095488-AF9DB581-1B8E-4777-9E81-25DFFFC51140

P1476

Q34095488-71C3340B-D36E-490C-83DD-998F5814C03C

P2093

Q34095488-2AB3BA56-54C4-409E-8884-1203A82EF176

Q34095488-56E9FCA0-CAC5-4906-AA54-EC09371DD20A

Q34095488-7A9C714A-37F6-48FD-8FA5-A5B331E38462

Q34095488-810C0174-E165-4AB0-BEC2-5CB3528BB58A

Q34095488-934E7246-B7A5-4B60-89F4-F88BCBADE329

Q34095488-A7EABDE5-A3C9-4428-B43B-A1D0A1F7E915

Q34095488-EFABCAD7-A303-4BE4-B650-AC7E8C1071C5

P2860

Q34095488-01B6E5D4-921A-4507-B5D3-052024C6EF5C

Q34095488-05509D8C-19A8-49F3-9BC6-51A5695EF64B

Q34095488-0CBCA450-FE35-49AA-8FA5-747E36B1CEE3

Q34095488-0D7CBE37-186E-47EB-A70B-7008C25F69E5

Q34095488-0F2C66D9-60D2-4D13-A891-1EBA79EE77A3

Q34095488-1CA71143-CA8A-4A45-859D-A26ABC335FAD

Q34095488-23F2C3D0-267F-4848-9D8F-869A0927AC14

Q34095488-30F6A5F5-A7A5-4750-895B-E06C1E6EAEF0

Q34095488-33B5B4C3-4EC0-47CB-ABD6-5659EAEEA42A

Q34095488-3612EB0A-61F9-4464-85EC-D6327E89E792

P304

Q34095488-FD51911E-C1AC-48F7-A273-CDB1D130ADD9

P31

Q34095488-5ED8AED9-D057-4D63-8631-3D3862336AC5

P356

Q34095488-1D239D10-14DD-4225-A06D-DBAE59713537

P407

Q34095488-9143CA1A-EDE7-45F4-920C-E6A458A04BC8

P433

Q34095488-7F557BCA-2089-4FD3-9B3D-22611791404B

P478

Q34095488-5DD1391D-6E87-4D83-8BBF-D906B7BC4ACC

P577

Q34095488-E7E56DCF-ED75-4590-B19D-B1C6DD6B1121

P698

Q34095488-86B832DA-2B35-4992-ABCF-8C606B2E47A7

P932

Q34095488-8A6A4A58-952B-4912-9748-1ECDA017DEDD

P356

J.ISSN.1673-5374.2013.23.004

P1433

Neural Regeneration Research

P1476

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke

@en

P2093

Haiping Zhao

http://www.w3.org/2001/XMLSchema#string

Lianqiu Min

http://www.w3.org/2001/XMLSchema#string

Lin Cong

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Shuai Shao

http://www.w3.org/2001/XMLSchema#string

Xiaoning Wu

http://www.w3.org/2001/XMLSchema#string

Yumin Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I

Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia

The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy

Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.

P304

2144-2154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3969/J.ISSN.1673-5374.2013.23.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25206523

http://www.w3.org/2001/XMLSchema#string

P932

4146119

http://www.w3.org/2001/XMLSchema#string